期刊文献+

康达心口服液对心肾综合征大鼠氧化应激的影响 被引量:2

Effect of Kangdaxin Oral Liquid on oxidative stress in rats with cardiorenal syndrome
下载PDF
导出
摘要 目的探讨康达心口服液对心肾综合征(CRS)大鼠的影响及潜在机制。方法将60只SD大鼠随机分为5组:假手术(sham)组、心力衰竭(HF)组、CRS组、HF干预(HF+I)组、CRS干预(CRS+I)组,通过心脏彩超测量各组大鼠左室射血分数(LVEF)、左室缩短分数(FS);通过ELISA法检测血清氨基末端脑钠肽前体(NT-proBNP)、肌酐(Cr)、尿素氮(Bun)、总抗氧化能力(T-AOC)、超氧化物歧化酶(SOD)、丙二醛(MDA)水平。结果HF组、HF+I组、CRS组、CRS+I组大鼠的FS及LVEF值低于sham组,血清NT-proBNP水平高于sham组,差异有统计学意义(P<0.05)。HF+I组的FS及LVEF值高于HF组,NT-proBNP水平低于HF组,差异有统计学意义(P<0.05)。CRS+I组的FS及LVEF值高于CRS组,NT-proBNP水平低于CRS组,差异有统计学意义(P<0.05)。CRS组、CRS+I组大鼠的血清Cr及Bun水平高于sham组,差异有统计学意义(P<0.05)。CRS+I组的血清Cr及Bun水平低于CRS组,差异有统计学意义(P<0.05)。HF组、HF+I组、CRS组、CRS+I组的血清T-AOC、SOD水平低于sham组,MDA水平高于sham组,差异有统计学意义(P<0.05)。HF+I组大鼠的血清T-AOC、SOD水平高于HF组、MDA水平低于HF组,差异有统计学意义(P<0.05)。CRS+I组大鼠的血清TAOC、SOD水平高于CRS组,MDA水平低于CRS组,差异有统计学意义(P<0.05)。结论康达心改善CRS大鼠心功能的效应,可能是通过提高抗氧化能力、抑制氧化应激实现的。 Objective To investigate the effect and potential mechanism of Kangdaxin Oral Liquid on cardiorenal syndrome(CRS)rats.Methods Sixty SD rats were randomly divided into 5 groups:sham operation(sham)group,heart failure(HF)group,CRS group,HF+intervention(I)group and CRS+I group.Left ventricular ejection fraction(LVEF)and left ventricular shortening fraction(FS)were measured by cardiac color ultrasound.The levels of serum N-terminal pro-B type natriuretic peptide(NT-proBNP),creatinine(Cr),urea nitrogen(Bun),total antioxidant capacity(T-AOC),superoxide dismutase(SOD),malondialdehyde(MDA)were determined by ELISA.Results The FS and LVEF values of rats in HF group,HF+I group,CRS group and CRS+I group were lower than those in sham group,and serum NT-proBNP level was higher than that in sham group,the differences were statistically significant(P<0.05).The FS and LVEF values in HF+I group were higher than those in HF group,and the level of NT-proBNP was lower than that in HF group,the differences were statistically significant(P<0.05).The FS and LVEF values of CRS+I group were higher than those of CRS group,and the level of NT-proBNP was lower than that of CRS group,the differences were statistically significant(P<0.05).The levels of serum Cr and Bun in CRS group and CRS+I group were higher than those in sham group,and the differences were statistically significant(P<0.05).The levels of serum Cr and Bun in CRS+I group were lower than those in CRS group,the differences were statistically significant(P<0.05).Serum T-AOC and SOD levels in HF group,HF+I group,CRS group and CRS+I group were lower than those in sham group,while MDA level was higher than that in sham group,the differences were statistically significant(P<0.05).Serum T-AOC and SOD levels in HF+I group were higher than those in HF group,while MDA levels were lower than those in HF group,the differences were statistically significant(P<0.05).Serum T-AOC and SOD levels in CRS+I group were higher than those in CRS group,while MDA levels were lower than those in CRS group,the differences were statistically significant(P<0.05).Conclusion Kangdaxin Oral Liquid may improve cardiac function in rats with cardiorenal syndrome by promoting antioxidant capacity and suppressing oxidative stress.
作者 吴翔 张婷婷 熊尚全 WU Xiang;ZHANG Tingting;XIONG Shangquan(Department of Cardiology,Affiliated People′s Hospital of Fujian University of Traditional Chinese Medcine,Fujian Province,Fuzhou350004,China)
出处 《中国当代医药》 CAS 2022年第14期10-13,共4页 China Modern Medicine
基金 福建省教育厅中青年教师教育科研项目(JAT170281)。
关键词 康达心口服液 心肾综合征 氧化应激 总抗氧化能力 超氧化物歧化酶 Kangdaxin Oral Liquid Cardionrenal syndrome Oxidative stress Total antioxidant capacity Superoxide dismutase
  • 相关文献

参考文献4

二级参考文献29

  • 1董兆强,郭静,鹿庆华,郝林,蒋卫东,齐昕.充血性心力衰竭患者血清基质金属蛋白酶-9的变化及临床意义[J].新医学,2006,37(6):360-361. 被引量:12
  • 2全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:710
  • 3张美燕,郑兴.基质金属蛋白酶-9在心血管疾病中的研究进展[J].心血管病学进展,2007,28(1):88-91. 被引量:7
  • 4D ' Armient J. Matrixm, et al. loproteinase, disruption of extracelluar ma- trix and cardial dysfunction[ J]. Trends Cardiovasc Med ,2002,12 (3) : 97.
  • 5中华医学会心血管病学分会,中华心血管病杂志编辑委员会.慢性心力衰竭诊断治疗指南[J].2007,35(12):1077-1078.
  • 6中华人民共和国卫生部药政司.中药新药临床研究指导原则[M],1993;57-58.
  • 7Feldman AM, Li YY, McTiernan CF. Matrix metalloproteinases in pathophysiology and treatment of heart failure[J]. Lancet, 2001,3,357 (9257) :654 -655.
  • 8Spinale F G, Coker M L, Heung L J, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocar- dium and is up regulated in heart failure [ J]. Circulation, 2000,102 (16) :1944 - 1949.
  • 9Li Y Y, Feng Y, McTiernan C F, et al. Downregulation of matrix metal- loproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices [ J ]. Circulation,2001,104 (10) : 1147 - 1152.
  • 10Ronco C, Haapio M, House A A, et al. Cardiorenal syndrome [J]. J AmCoI1Cardiol, 2008, 52 (19): 1527-1539.

共引文献15

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部